Editor Name: Yavuz S. Silay
Country: Turkey
Designation: Chairman of Istanbul Consulting Group
Biography:Â
Chairman of Istanbul Consulting Group (ICG) -BioPharma CEO, Carveout, Turnaround Specialist-Businessman, Entrepreneur Doctor & "International Healthcare Executive (Pharmaceutical, Diagnostic & Medical Device)", Management Consultant, "Business, Strategy, Marketing Savvy Physician-Board member of ICG,SKYDER, BID,SEPD & narteg-Previously Managed the largest distributor of Siemens Diagnostics in Turkey with ~220 employees- Worked in USA as VP of Ipsen, Director at Teva, Associate Director at KV, Physician Scientist at Forest Pharmaceutical & Clinical Research Director at Baylor- Team player, Silobuster, Get Things Done-- Formerly Providing strategic guidance to the Research Based Pharmaceutical Companies & at The World Bank for ministry of health in the area of organ transplant , cell & tissue banking- Proven ability to build high performing teams & productive organizations, turn around brands & build revenue in diverse markets.
Multi-sector business experience including the healthcare, finance and energy sectors. ICG is a seeker of knowledge and trend watcher. ICG's areas of interest are interdisciplinary, with deep expertise in new market entry & new product development in healthcare (pharmaceutical products, nutraceuticals, biotechnology, biologicals, medical device, healthcare policy, public health, pharmacoeconomics, clinical studies Phase1 through Phase 4), energy and finance sectorsÂ
Specialties: Pharmaceutical & medical device portfolio management, Laboratory management, R&D center accreditation and management, Lean Start-ups, M & A, Roll Up, International Marketing and Business Development, Technology due diligence, Medical Tourism, Project Management, Market Research, Market Segmentation, Data Driven Strategy, New Formulations, Entrepreneurship, enterprise management, startup management, new market entry management, new product management.
• He is a Advisory Board Member at the Rutgers University Center for Innovation Education Big Data Certificate Program.
• Avcılar Hospital R & D Center started to operate as the first and only private hospital approved R & D center of Turkey.
• As part of a project funded by The World Bank for the reform in Turkish health care sector providing strategic guidance in the development of Cell and Tissue banking infrastructure.\
• Lead Medical affairs, Neurology in the US for Ipsen, a midsize French specialty biopharmaceutical company.
• Lead Medical affairs Neurology department in US. Support US franchise portfolio development through medical guidance & coordination, in short and long term strategic planning, alignment of projects, clinical studies and medical information, in close cooperation with all medical functions across organization with US Franchise Marketing and Market access team and with global headquarters.
• Directed Rasagiline clinical trials, Investigator Initiated Studies and other external investigations conducted in United States. Provided clinical input throughout the various business units of the organization. Developed and executed clinical programs for company products. Directed study design, protocol development and executed clinical studies. Acted as a liaison between the company and clinical investigators, domestic & international neurology societies.
• Successfully contributed to a NDA submission and to the design and implementation of Phase IIIb program, involved in the clinical development of drug trials related to several rheumatologic, neurological and psychiatric disorders
• Participates in all aspects of clinical development and study management, which includes providing scientific, and/or logistical direction and support to planned and ongoing trials.• Clinical development in CNS and Rheumatology therapeutic area.
• Knowledge of CNS related scales specific to variety of diseases including Alzheimer, Parkinson’s, Tourette Syndrome and Huntington’s disease.• Author drafts of study synopses, protocols, protocol amendments, Monitoring Plan and informed consents for Phase II-IV studies.
• Senior Clinical Research Coordinator at Baylor College of Medicine
Award: Young Investigator Clinical Research Award
.gif)
.png)
.jpg)
